NEPHROS INC (NEPH) Stock Price, Forecast & Analysis

NASDAQ:NEPH • US6406714005

4 USD
-0.02 (-0.5%)
Last: Feb 26, 2026, 08:00 PM

NEPH Key Statistics, Chart & Performance

Key Statistics
Market Cap42.52M
Revenue(TTM)17.93M
Net Income(TTM)1.48M
Shares10.63M
Float9.43M
52 Week High6.42
52 Week Low1.39
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.13
PE30.77
Fwd PE26.14
Earnings (Next)03-05
IPO2004-09-21
Sector
GICS SectorIndustrials
GICS IndustryMachinery
GICS IndustryGroupCapital Goods
NEPH short term performance overview.The bars show the price performance of NEPH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15

NEPH long term performance overview.The bars show the price performance of NEPH in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200 250

The current stock price of NEPH is 4 USD. In the past month the price decreased by -11.31%. In the past year, price increased by 164.9%.

NEPHROS INC / NEPH Daily stock chart

NEPH Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to NEPH. When comparing the yearly performance of all stocks, NEPH is one of the better performing stocks in the market, outperforming 94.44% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
NEPH Full Technical Analysis Report

NEPH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to NEPH. While NEPH has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NEPH Full Fundamental Analysis Report

NEPH Financial Highlights

Over the last trailing twelve months NEPH reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 244.44% compared to the year before.


Industry RankSector Rank
PM (TTM) 8.26%
ROA 11.18%
ROE 14.8%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%35.42%
EPS 1Y (TTM)244.44%
Revenue 1Y (TTM)32.36%
NEPH financials

NEPH Forecast & Estimates

8 analysts have analysed NEPH and the average price target is 7.14 USD. This implies a price increase of 78.5% is expected in the next year compared to the current price of 4.

For the next year, analysts expect an EPS growth of 3233944820422206000% and a revenue growth 33.54% for NEPH


Analysts
Analysts82.5
Price Target7.14 (78.5%)
EPS Next Y3233944820422206000%
Revenue Next Year33.54%
NEPH Analyst EstimatesNEPH Analyst Ratings

NEPH Ownership

Ownership
Inst Owners47.19%
Ins Owners10.85%
Short Float %0.1%
Short Ratio0.2
NEPH Ownership

NEPH Competitors/Peers

The largest stocks on the US markets in the "Industrial Machinery & Supplies & Components" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
PH PARKER HANNIFIN CORP29128.11B
ITW ILLINOIS TOOL WORKS25.5284.21B
IR INGERSOLL-RAND INC25.7737.35B
OTIS OTIS WORLDWIDE CORP20.5535.552B
SYM SYMBOTIC INC59.7334.577B
XYL XYLEM INC23.532.121B
DOV DOVER CORP21.3531.152B
SNA SNAP-ON INC18.8620.111B
FTV FORTIVE CORP20.8318.741B
RBC RBC BEARINGS INC42.2818.229B

About NEPH

Company Profile

NEPH logo image Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

Company Info

NEPHROS INC

380 Lackawanna Pl

South Orange NEW JERSEY 07079 US

CEO: Andrew Astor

Employees: 31

NEPH Company Website

NEPH Investor Relations

Phone: 12013435202

NEPHROS INC / NEPH FAQ

What does NEPH do?

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.


Can you provide the latest stock price for NEPHROS INC?

The current stock price of NEPH is 4 USD. The price decreased by -0.5% in the last trading session.


What is the dividend status of NEPHROS INC?

NEPH does not pay a dividend.


What is the ChartMill technical and fundamental rating of NEPH stock?

NEPH has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the market expecting NEPH stock to perform?

8 analysts have analysed NEPH and the average price target is 7.14 USD. This implies a price increase of 78.5% is expected in the next year compared to the current price of 4.


What sector and industry does NEPHROS INC belong to?

NEPHROS INC (NEPH) operates in the Industrials sector and the Machinery industry.


What is the employee count for NEPH stock?

NEPHROS INC (NEPH) currently has 31 employees.